Gilead : CHMP Grants Positive Opinion For Use Of Veklury In COVID-19 Patients With Renal Impairment
26/5 07:17
(RTTNews) - Gilead Sciences Inc. (GILD) said Friday that the Committee for Medicinal Products for Human Use or CHMP of the European Medicines Agency (EMA) granted a positive opinion for the use of Veklury (remdesivir) in COVID-19 patients with severe renal impairment, including t...